Methallylescaline

Methallylescaline (also known as 4-methallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is a phenethylamine in the escaline family. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines I Have Known And Loved), the dosage range is listed as 40-60 mg, and the duration is listed as 10-15 hours.

Chemistry

Methallylescaline, or 4-methallyloxy-3,5-dimethoxyphenethylamine, is a synthetic alkaloid of the phenethylamine class. It is structurally related to other phenethylamine psychedelics such as mescaline and escaline. The full name of the chemical is 2-(4-methallyloxy-3,5-dimethoxyphenyl)ethanamine.

Pharmacology

The exact mechanism of action of methallylescaline is not known. However, like other phenethylamines, it is believed to act primarily as a 5-HT2A receptor agonist. This receptor is involved in the serotonin system, which is known to play a key role in the psychedelic experience.

Effects

The effects of methallylescaline are reported to be similar to those of other psychedelic phenethylamines, and include hallucinations, altered thinking processes, and a heightened sense of awareness. The experience can vary greatly depending on the individual, the dose taken, and the setting in which it is used.

Legal Status

The legal status of methallylescaline varies by country. In the United States, it is not specifically listed as a controlled substance, but it could potentially be considered an analog of a controlled substance under the Federal Analogue Act.

See Also

• Phenethylamine
• Psychedelic drug
• Mescaline
• Escaline
• PiHKAL

This psychedelic-related article is a stub. You can help WikiMD by expanding it.